Prosecution Insights
Last updated: October 04, 2026

Electroceuticals LLC

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Electroceuticals LLC currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This active matter is assigned to 1 distinct examiner and is being processed within 1 distinct art unit. The prosecution profile shows a singular focus, with the company's current intellectual property efforts concentrated in a specific area of mechanical and medical innovation.

The busiest examiner for the portfolio is HULBERT, AMANDA K, who is overseeing the 1 pending office action. As HULBERT, AMANDA K handles the only pending action for the company, the prosecution strategy is entirely focused on addressing the specific concerns of this individual. The alignment of the busiest examiner's workload with the total pending actions suggests a streamlined administrative process.

The presence of 1 distinct art unit for the 1 pending office action confirms that the company is not currently facing multiple simultaneous examinations across different USPTO departments. Practitioners can focus their efforts on the specific standards of the Medical Devices & Mechanical Engineering sector. This centralized workload minimizes the complexity of the company's current patent prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HULBERT, AMANDA K 1 84.6% +4.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18594416 SYSTEMS, METHODS AND DEVICES FOR BIOELECTRONIC NEUROCODE-BASED MEDICAL TREATMENT HULBERT, AMANDA K 12d

Top Art Units

Art UnitApps
3792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18594416 SYSTEMS, METHODS AND DEVICES FOR BIOELECTRONIC NEUROCODE-BASED MEDICAL TREATMENT HULBERT, AMANDA K 3792 DP Final Rejection 12d Pending Mar 04, 2024

Managing Electroceuticals LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month